Log in

Relevant bibliographies by topics / Monoclonal Gammapathies / Journal articles

To see the other types of publications on this topic, follow the link: Monoclonal Gammapathies.

Journal articles on the topic 'Monoclonal Gammapathies'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Monoclonal Gammapathies.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Imhof, J. W., R. E. Ballieux, N. A. J. Mul, and H. Poen. "Monoclonal and Diclonal Gammapathies." Acta Medica Scandinavica 179, S445 (2009): 102–8. http://dx.doi.org/10.1111/j.0954-6820.1966.tb02347.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Malati, T. "An overview of monoclonal gammapathies." Indian Journal of Clinical Biochemistry 16, no. 1 (2001): 1–8. http://dx.doi.org/10.1007/bf02867561.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pika, T., P. Flodr, M. Novák, et al. "Clinical Problems of IgM Monoclonal Gammapathies." Klinická biochemie a metabolismus 22, no. 2 (2014): 61–64. https://doi.org/10.61568/kbm.2014.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

R Sindhu, Edakkadath, Aptha Y. Das, Maya Padmanabhan, and Chandran K Nair. "Correlation of Plasma Cell Percentage and Monoclonal Gammapathies with Biochemical Parameters in Multiple Myeloma Patients: A Retrospective Study." Asian Pacific Journal of Cancer Care 8, no. 4 (2023): 685–89. http://dx.doi.org/10.31557/apjcc.2023.8.4.685-689.

Full text

Abstract:

Background: Multiple myeloma is characterized by the uncontrolled proliferation of monoclonal plasma cells in the bone marrow, leading to the production of non-functional intact immunoglobulin chains. This retrospective study aimed to investigate the correlation between plasma cell percentage (below 60% and above 60%) in different types of monoclonal gammapathies (IgA, IgG) and various biochemical parameters.Methods: This analysis was conducted at the Division of Biochemistry in the Malabar Cancer Centre, a tertiary care cancer center in Kerala, India. A total of 89 patient case reports were r

APA, Harvard, Vancouver, ISO, and other styles

5

VAN DEN AKKER, THEODOOR W., ROBBERT BENNER, and JIRI RADL. "TRANSIENT MONOCLONAL GAMMAPATHIES WITH LAMBDA LIGHT CHAINS." Transplantation 44, no. 5 (1987): 725. http://dx.doi.org/10.1097/00007890-198711000-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Dammacco, Franco, and Jan Waldenström. "BENCE JONES PROTEINURIA IN BENIGN MONOCLONAL GAMMAPATHIES." Acta Medica Scandinavica 184, no. 1-6 (2009): 403–9. http://dx.doi.org/10.1111/j.0954-6820.1968.tb02479.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Malati, T., B. Yadagiri, D. Murali Mohan Krishna, V. Shantaram, D. Raghunadharao, and K. Subbarao. "Spectrum of monoclonal gammapathies in Andhra Pradesh." Indian Journal of Clinical Biochemistry 16, no. 1 (2001): 52–59. http://dx.doi.org/10.1007/bf02867568.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Radl, J., R. M. Valentijn, J. J. Haaijman, and L. C. Paul. "Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation." Clinical Immunology and Immunopathology 37, no. 1 (1985): 98–102. http://dx.doi.org/10.1016/0090-1229(85)90140-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lubimova, N. V., T. A. Turko, O. M. Votyakova, and N. E. Kushlinskii. "Serum Immunoglobulin Free Light Chains in Patients with Monoclonal Gammapathies." Bulletin of Experimental Biology and Medicine 153, no. 2 (2012): 249–54. http://dx.doi.org/10.1007/s10517-012-1688-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mahjouba-Baiya, Khannouri Imane-El, Amrani Youssra-El, Saliha-Chellak, and Abderrahman-Boukhira. "Monoclonal gammapathies: Epidemiological, immunochemical and etiological analysis of a series of 50 cases." GSC Biological and Pharmaceutical Sciences 29, no. 1 (2024): 175–78. https://doi.org/10.5281/zenodo.14716002.

Full text

Abstract:

During the period from September 2022 to January 2023, 50 cases of monoclonal gammopathy (GM) were collected at the Avicenne military hospital in Marrakech. The average age of the patients was 62 years. Thirty patients were male and 20 were female. The etiological diagnosis could be established for the 50 observations: 5 were classified as GM of undetermined significance (GMSI), 42 were classified as myeloma, two case of Waldenström's disease and one case of AL amyloidosis. The clinical symptomatology was dominated by bone pain in 78% of patients with a deterioration in general condition

APA, Harvard, Vancouver, ISO, and other styles

11

Radl, Jiri. "Age-related monoclonal gammapathies: clinical lessons from the aging C57BL mouse." Immunology Today 11 (January 1990): 234–36. http://dx.doi.org/10.1016/0167-5699(90)90096-r.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Lyubimova, N. V., Y. S. Timofeev, E. G. Gromova, O. M. Votyakova, N. A. Ognerubov, and N. E. Kushlinskii. "SELECTIVE ELIMINATION OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN PATIENTS WITH MONOCLONAL GAMMAPATHIES." Tambov University Reports. Series: Natural and Technical Sciences 22, no. 1 (2017): 142–47. http://dx.doi.org/10.20310/1810-0198-2017-22-1-142-147.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Mahjouba-Baiya, Imane-El Khannouri, Youssra-El Amrani, Saliha-Chellak, and Abderrahman-Boukhira. "Monoclonal gammapathies: Epidemiological, immunochemical and etiological analysis of a series of 50 cases." GSC Biological and Pharmaceutical Sciences 29, no. 1 (2024): 175–78. http://dx.doi.org/10.30574/gscbps.2024.29.1.0383.

Full text

Abstract:

During the period from September 2022 to January 2023, 50 cases of monoclonal gammopathy (GM) were collected at the Avicenne military hospital in Marrakech. The average age of the patients was 62 years. Thirty patients were male and 20 were female. The etiological diagnosis could be established for the 50 observations: 5 were classified as GM of undetermined significance (GMSI), 42 were classified as myeloma, two case of Waldenström's disease and one case of AL amyloidosis. The clinical symptomatology was dominated by bone pain in 78% of patients with a deterioration in general condition in 43

APA, Harvard, Vancouver, ISO, and other styles

14

Hestin, D., N. Petitpain, D. Mayeux, et al. "Influence of chronic rejection on the occurrence of monoclonal gammapathies in renal transplant patients." Clinical Transplantation 7, no. 1pt1 (1993): 59–64. http://dx.doi.org/10.1111/j.1399-0012.1993.tb00877.x.

Full text

Abstract:

To assess the frequency of monoclonal gammapathies (MG) and their origin in immunosuppressed renal transplant patients, a prospective study was conducted in 164 patients who underwent 165 consecutive renal transplantations (RT) from April 1986 to August 1991. Sera were tested by cellulose acetate electrophoresis before RT and every 3 months after RT, and those containing a monoclonal component were further investigated by immunoelectrophoresis and/or immunofixation. The immunosuppressive regimen in 69 cases (41.8%) consisted of the association cyclosporinc ‐ prednisone while 96 patients (58.2%

APA, Harvard, Vancouver, ISO, and other styles

15

Michiels, Jan Jacques, and Huub H. D. M. van Vliet. "Acquired von Willebrand Disease in Monoclonal Gammapathies: Effectiveness of High-dose Intravenous Gamma Globulin." Clinical and Applied Thrombosis/Hemostasis 5, no. 3 (1999): 152–57. http://dx.doi.org/10.1177/107602969900500302.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

FISCHER, ANNE MARIE, FRÉDÉRIQUE SIMON, FRANÇOISE LE DEIST, STÉPHANE BLANCHE, CLAUDE GRISCELLI, and ALAIN FISCHER. "PROSPECTIVE STUDY OF THE OCCURRENCE OF MONOCLONAL GAMMAPATHIES FOLLOWING BONE MARROW TRANSPLANTATION IN YOUNG CHILDREN." Transplantation 49, no. 4 (1990): 731–34. http://dx.doi.org/10.1097/00007890-199004000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Torreguitart, F., E. Agriello, P. Iommi, et al. "PB2108 CIRCULATING PLASMA CELLS: AN APPROACH BASED ON NEXT GENERATION FLOW TOOLS IN MONOCLONAL GAMMAPATHIES." HemaSphere 3, S1 (2019): 949. http://dx.doi.org/10.1097/01.hs9.0000566916.48165.e1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Radl, J., M. Liu, C. M. Hoogeveen, et al. "Monoclonal gammapathies in long-term surviving Rhesus monkeys after lethal irradiation and bone marrow transplantation." Clinical Immunology and Immunopathology 60, no. 2 (1991): 305–9. http://dx.doi.org/10.1016/0090-1229(91)90073-j.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ernestho-ghoud, Indretsy Mahavivola, Moustafa Abdou Soilihi, Ny Ony Narindra Lova Hasina Rajaonarison, Nasolotsiry Enintsoa Raveloson, Ahmad Ahmad, and Hanta Marie Danielle Vololontiana. "Association entre gammapathie monoclonale de signification indéterminée et thrombose veineuse cérébrale : Une observation clinique inhabituelle." Annales Africaines de Medecine 16, no. 3 (2023): 5244–48. http://dx.doi.org/10.4314/aamed.v16i3.10.

Full text

Abstract:

Cerebral venous thrombosis associated to the monoclonal gammopathy of undetermined significance has been rarely reported. In this paper, we discuss the case of 68-year-old man who presented repeated comitial. A cerebral Magnetic Resonance Imaging (MRI) showed cerebral venous thrombosis. The only biological abnormality highlighted was high level of monoclonal gammaglobulin. The coexistence of cerebral venous thrombosis and the monoclonal gammopathy of undetermined significance were fortuitous without causality links. French Abstract La thrombose veineuse cérébrale est rarement assoc

APA, Harvard, Vancouver, ISO, and other styles

20

Campos-Cabrera, Gregorio, Salvador Campos-Cabrera, Virgina Campos-Cabrera, et al. "Prevalence of Immunophenotypes in Neoplastic Hematology At Laboratorios Fatima De Michoacan." Blood 120, no. 21 (2012): 4829. http://dx.doi.org/10.1182/blood.v120.21.4829.4829.

Full text

Abstract:

Abstract Abstract 4829 Introduction: Medical indication of flow cytometric immunophenotyping includes diagnosis, classification, prognosis and disease monitoring. This is an important tool that each time is more used in hematology. Third world countries could not stay away from this technology, effort should be made to get access to it and not only make diagnosis in morphology. Objective: To determinate the prevalence of immunophenotypes in neoplastic hematology in our region (Central-West Mexico). Material and Methods: Bone marrow samples referred to Laboratorios Fatima de Michoacan for flow

APA, Harvard, Vancouver, ISO, and other styles

21

Nooij, F. J. M., A. J. van der Sluijs-Gelling, and J. Radl. "Development of aging-associated monoclonal gammapathies with antibody activity to the antigen used for immunization of young mice." Clinical Immunology and Immunopathology 63, no. 2 (1992): 110–14. http://dx.doi.org/10.1016/0090-1229(92)90002-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Decaux, Olivier, Helene Leroy, Jean-Christophe Ianotto, et al. "Clinical and Biological Features of Biclonal Gammopathies. Review of 203 Cases." Blood 112, no. 11 (2008): 5151. http://dx.doi.org/10.1182/blood.v112.11.5151.5151.

Full text

Abstract:

Abstract Introduction: Biclonal gammopathies represent about 5% of clonal gammopathies. We describe the clinical and laboratory features of biclonal gammopathies identified in a French university hospital. Methods: Patients were selected by immunofixation registry of Biochemistry laboratory. Results: From 1987 to 2008, 203 biclonal gammapathies were identified. Patients were 113 men and 90 women. Median age was 72.0 years (35–95). Seventy eight patients (38.3%) had IgG and IgM components, 64 (31,9%) had two IgG, 24 (11,8%) had IgG and IgA, 23 (11,3%) had two IgM, 8 (3,9%) had IgM and IgA, 5 (2

APA, Harvard, Vancouver, ISO, and other styles

23

van den Akker, T. W., R. Brondijk, and J. Radl. "Influence of Long-Term Antigenic Stimulation Started in Young C57BL Mice on the Development of Age-Related Monoclonal Gammapathies." International Archives of Allergy and Immunology 87, no. 2 (1988): 165–70. http://dx.doi.org/10.1159/000234667.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

González, I. Liria, D. Melero López, N. M. Barbosa De Carvalho, C. Tejedor Díaz, and P. Puerta Fonollá. "Can the sFLC assay help on the optimization of the use of 24h urines in patients with monoclonal gammapathies?" Clinica Chimica Acta 493 (June 2019): S420. http://dx.doi.org/10.1016/j.cca.2019.03.894.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Demyanets, S., A. Kaider, R. Thalhammer, et al. "Choice of proper approach for the assessment of plasma cells in the bone marrow of patients with monoclonal gammapathies." Clinica Chimica Acta 493 (June 2019): S428. http://dx.doi.org/10.1016/j.cca.2019.03.910.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Vávrová, J., P. Kušnierová, V. Maisnar, and L. Šolcová. "Recommendation of the Czech Society of Clinical Biochemistry and the Czech Myeloma Group to laboratory diagnostics of monoclonal gammapathies." Klinická biochemie a metabolismus 28, no. 1 (2020): 26–34. https://doi.org/10.61568/kbm.2020.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Chauvet, S., L. Roumenina, M. Dragon-Durey, M. Marinozzi, F. Bridoux, and V. Frémeaux-Bacchi. "Mécanismes d’activation de la voie alterne au cours des glomérulopathies à dépôts de C3 associées aux gammapathies monoclonales : rôle des Ig polyclonales et du composant monoclonal." Néphrologie & Thérapeutique 12, no. 5 (2016): 279–80. http://dx.doi.org/10.1016/j.nephro.2016.07.361.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Askari, Elham, David F. Moreno, Fernando Escalante, et al. "Clinical Characteristics, Treatment Approach and Long-Term Outcomes of 678 Patients with Symptomatic Waldenstrom's Macroglobulinemia: Comprehensive Insights from a Spanish Registry of IgM Gammapathies." Blood 142, Supplement 1 (2023): 4406. http://dx.doi.org/10.1182/blood-2023-189581.

Full text

Abstract:

Introduction The pathogenesis of Waldenstrom's macroglobulinemia (WM) involves the clonal expansion of lymphoplasmacytic B cells in bone marrow, producing monoclonal immunoglobulin M (IgM). The heterogeneity of clinical manifestations in this uncommon disease represents the treatment approach more challenging. Multicenter registries may help in improving health care and scientific research. PRAME is a Spanish national registry of WM and IgM-related disorders with comprehensive data collection, providing insights for a better understanding of WM. Methods This is a retrospective, multicenter stu

APA, Harvard, Vancouver, ISO, and other styles

29

Makni, S., R. Zouari, M. R. Barbouch, Kh Ayed, M. Moalla, and L. Zakraoui. "Gammapathies monoclonales en Tunisie." Revue Française de Transfusion et d'Hémobiologie 33, no. 1 (1990): 31–38. http://dx.doi.org/10.1016/s1140-4639(05)80003-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Wendling, Daniel, Clément Prati, Jean-Marie Berthelot, Pascal Claudepierre, and Thao Pham. "Spondylarthrite et gammapathie monoclonale." Revue du Rhumatisme 79, no. 4 (2012): 367–68. http://dx.doi.org/10.1016/j.rhum.2011.10.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

YOUINOU, P., J. JOUQUAN, and C. GERARD. "Les gammapathies monoclonales non malignes." Revue Francaise de Transfusion et Immuno-hématologie 29, no. 2 (1986): 81–96. http://dx.doi.org/10.1016/s0338-4535(86)80024-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

BOUCHE, P. "Polyneuropathies associees aux gammapathies monoclonales." Revue d&'apos;Electroencéphalographie et de Neurophysiologie Clinique 17 (May 1987): 29s. http://dx.doi.org/10.1016/s0370-4475(87)80004-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Dupont, J., K. Paricaud, J. Perreira, et al. "Kératopathie cristalline des gammapathies monoclonales." La Revue de Médecine Interne 39 (December 2018): A162. http://dx.doi.org/10.1016/j.revmed.2018.10.119.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Moreau, Philippe. "Gammapathies monoclonales de signification indéterminée." EMC - Hématologie 1, no. 1 (2006): 1–5. http://dx.doi.org/10.1016/s1155-1984(03)00045-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Touzeau, C., and P. Moreau. "Gammapathies monoclonales de signification indéterminée." EMC - Hématologie 7, no. 2 (2012): 1–6. http://dx.doi.org/10.1016/s1155-1984(12)55411-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Pascal, Virginie, Vincent Javaugue, Sebastien Bender, Christophe Sirac, and Frank Bridoux. "Gammapathies monoclonales de signification rénale." Revue Francophone des Laboratoires 2024, no. 560 (2024): 24–35. http://dx.doi.org/10.1016/s1773-035x(24)00106-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Cribier, B. "Spicules kératosiques et gammapathie monoclonale." Annales de Dermatologie et de Vénéréologie - FMC 1, no. 3 (2021): 198–200. http://dx.doi.org/10.1016/j.fander.2021.01.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

R., Kyle, and Therneau T. "Gammapathie monoclonale de signification indéterminée." Revue Francophone des Laboratoires 2006, no. 382 (2006): 19. http://dx.doi.org/10.1016/s1773-035x(06)80175-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Antoine, J. C. "Neuropathie et gammapathie monoclonale IGG." Revue Neurologique 168 (April 2012): A171—A172. http://dx.doi.org/10.1016/j.neurol.2012.01.444.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Dammak, N., Y. Chaabouni, I. Agrebi, et al. "Atteintes rénales associées aux gammapathies monoclonales." Néphrologie & Thérapeutique 14, no. 5 (2018): 350. http://dx.doi.org/10.1016/j.nephro.2018.07.226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

FINE, J., and M. MARNEUX. "Données récentes sur les Gammapathies monoclonales." Revue Francaise de Transfusion et Immuno-hématologie 28, no. 6 (1985): 591–600. http://dx.doi.org/10.1016/s0338-4535(85)80004-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Zandecki, M., F. Geneviève, P. Jego, and B. Grosbois. "Les gammapathies monoclonales de signification indéterminée." La Revue de Médecine Interne 21, no. 12 (2000): 1060–74. http://dx.doi.org/10.1016/s0248-8663(00)00267-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Hello, M., S. Barbarot, A. Néel, et al. "Manifestations cutanées associées aux gammapathies monoclonales." La Revue de Médecine Interne 35, no. 1 (2014): 28–38. http://dx.doi.org/10.1016/j.revmed.2013.08.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Lalive, Patrice H., Thierry Kuntzer, and Pierre-Yves Dietrich. "Neuropathies associées aux paraprotéinémies (gammapathies monoclonales)." Revue Médicale Suisse 9, no. 384 (2013): 929–33. http://dx.doi.org/10.53738/revmed.2013.9.384.0929.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Léeque, L., A. Turcu, P. Bielefeld, P. E. Charles, T. Petrella, and J. F. Besancenot. "Xanthogranulome nécrobiotique et gammapathie monoclonale transitoires." La Revue de Médecine Interne 22 (December 2001): 516s—517s. http://dx.doi.org/10.1016/s0248-8663(01)80201-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Smets, P., G. Guettrot-Imbert, A. F. Serre Sapin, et al. "Gammapathie monoclonale associée à une pseudohypofibrinogénémie." La Revue de Médecine Interne 34 (December 2013): A91—A92. http://dx.doi.org/10.1016/j.revmed.2013.10.150.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Lioger, B., and F. Maillot. "Angio-œdème acquis et gammapathie monoclonale." La Revue de Médecine Interne 31 (June 2010): S101. http://dx.doi.org/10.1016/j.revmed.2010.03.128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Émile, Carole. "Gammapathie monoclonale à activité auto-anticorps." Option/Bio 19, no. 406 (2008): 19. http://dx.doi.org/10.1016/s0992-5945(08)70247-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Cambier, Jean. "Un signal à interpréter : les gammapathies monoclonales." Option/Bio 20, no. 423 (2009): 6. http://dx.doi.org/10.1016/s0992-5945(09)70142-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Colombo, A., A. Sibille, R. Mondon, et al. "Gammapathie monoclonale et insuffisance rénale : apparences trompeuses !" Néphrologie & Thérapeutique 11, no. 5 (2015): 368–69. http://dx.doi.org/10.1016/j.nephro.2015.07.326.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!